Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine

Historical observation

20182026

Universe›Health Care›Pharmaceuticals›Pharmaceuticals

1 · Sector

Weight and 12M allocation change

Consumer Discretionary11.0%+3.71 pp Energy3.4%+1.21 pp Utilities3.5%+0.44 pp Health Care16.9%+0.44 pp Consumer Staples7.5%+0.40 pp Real Estate3.3%+0.12 pp Materials3.0%-0.22 pp Information Technology26.7%-0.60 pp Communication Services3.4%-0.97 pp Financials11.7%-2.06 pp Industrials9.7%-2.46 pp

2 · Industry

Inside Health Care

Managed Health Care2.54%+0.56 pp Pharmaceuticals5.28%+0.53 pp Health Care Equipment2.91%-0.33 pp Biotechnology2.41%-0.14 pp Health Care Supplies0.18%-0.13 pp Life Sciences Tools & Services2.09%-0.11 pp Health Care Distributors0.37%+0.07 pp Health Care Facilities0.22%-0.07 pp Health Care Services0.89%+0.05 pp Health Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Pharmaceuticals

Pharmaceuticals5.28%+0.531 pp

Concentrated

Most of this industry's gains came from a few companies.

View all contributions →

Pharmaceuticals · weight

5.28%

Industry change · 12M

+0.53 pp

Pharmaceuticals · contribution

+0.531 pp

Company participation

14%

of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Jul 2022 · sorted by absolute contribution to 12-month change

Company	Country	Market cap	Universe weight	3M contribution	12M contribution	12M price return	Above 6M weight average
Lilly (Eli) → LLY	United States	$313.3bn	1.077%	+0.073 pp	+0.276 pp	+37.3%	Yes
Pfizer → PFE	United States	$283.4bn	0.974%	-0.024 pp	+0.152 pp	+21.8%	No
Merck & Co. → MRK	United States	$225.9bn	0.776%	-0.034 pp	+0.109 pp	+20.4%	No
Zoetis → ZTS	United States	$85.9bn	0.295%	-0.007 pp	-0.035 pp	-9.4%	No
Bristol Myers Squibb → BMY	United States	$157.5bn	0.541%	-0.038 pp	+0.024 pp	+12.1%	No
Johnson & Johnson → JNJ	United States	$458.8bn	1.577%	-0.140 pp	+0.022 pp	+3.9%	No
Viatris → VTRS	United States	$11.7bn	0.040%	-0.005 pp	-0.018 pp	-28.7%	No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.